Search research articles
Contact Us
Filters
Showing results (231-240 of 520) with videos related to
Page
of 52
Sort By:
European Journal of Heart Failure
|
February 24, 2007
Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme
Nathaniel M Hawkins, Duolao Wang, John J V McMurray, et al.
Circulation
|
June 23, 2017
Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist)
Sheila M Hegde, Brian Claggett, Amil M Shah, et al.
Journal of the American College of Cardiology
|
September 25, 2007
The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study
Anil Verma, Nagesh S Anavekar, Alessandra Meris, et al.
European Heart Journal
|
April 1, 2021
The struggle towards a Universal Definition of Heart Failure-how to proceed?
John G F Cleland, Marc A Pfeffer, Andrew L Clark, et al.
Circulation
|
May 25, 2011
Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention
Siqin Ye, Matthew Grunnert, Jens Jakob Thune, et al.
JACC. Heart Failure
|
September 13, 2020
Associations Between Depressive Symptoms and HFpEF-Related Outcomes
Alvin Chandra, Michael A D Alcala, Brian Claggett, et al.
Circulation
|
July 7, 2005
Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease
Marcello Tonelli, Chris Isles, Timothy Craven, et al.
Journal of the American College of Cardiology
|
May 10, 2008
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both
L Michael Prisant, Kevin L Thomas, Eldrin F Lewis, et al.
Lancet (London, England)
|
August 18, 2009
Albuminuria in chronic heart failure: prevalence and prognostic importance
Colette E Jackson, Scott D Solomon, Hertzel C Gerstein, et al.
Circulation
|
October 7, 2004
Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program
Scott D Solomon, Duolao Wang, Peter Finn, et al.
Page
of 52
Search research articles
Search
Showing results (231-240 of 520) with videos related to
Sort By:
Page
of 52
European Journal of Heart Failure
|
February 24, 2007
Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme
Nathaniel M Hawkins, Duolao Wang, John J V McMurray, et al.
Circulation
|
June 23, 2017
Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist)
Sheila M Hegde, Brian Claggett, Amil M Shah, et al.
Journal of the American College of Cardiology
|
September 25, 2007
The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study
Anil Verma, Nagesh S Anavekar, Alessandra Meris, et al.
European Heart Journal
|
April 1, 2021
The struggle towards a Universal Definition of Heart Failure-how to proceed?
John G F Cleland, Marc A Pfeffer, Andrew L Clark, et al.
Circulation
|
May 25, 2011
Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention
Siqin Ye, Matthew Grunnert, Jens Jakob Thune, et al.
JACC. Heart Failure
|
September 13, 2020
Associations Between Depressive Symptoms and HFpEF-Related Outcomes
Alvin Chandra, Michael A D Alcala, Brian Claggett, et al.
Circulation
|
July 7, 2005
Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease
Marcello Tonelli, Chris Isles, Timothy Craven, et al.
Journal of the American College of Cardiology
|
May 10, 2008
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both
L Michael Prisant, Kevin L Thomas, Eldrin F Lewis, et al.
Lancet (London, England)
|
August 18, 2009
Albuminuria in chronic heart failure: prevalence and prognostic importance
Colette E Jackson, Scott D Solomon, Hertzel C Gerstein, et al.
Circulation
|
October 7, 2004
Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program
Scott D Solomon, Duolao Wang, Peter Finn, et al.
Page
of 52